Malignancy, autoimmune disease, and inherited or acquired thrombophilias were all ruled out based on normal tumor markers (CA 19–9, CEA, AFP), ANA, antiphospholipid antibody panel, and imaging findings. This evidence concerns the gene AFP and neoplasm.